Gelonghui September 1st 丨Unnamed Pharmaceutical (002581.SZ) announced that according to the “Notice of the Xiamen Municipal People's Government on Certain Measures to Accelerate the High-Quality Development of the Biomedical Industry” (Xiamen Regulation (2020) No. 7), Unnamed Biomedical Co., Ltd. (“Xiamen Weiming”), a wholly-owned subsidiary of Shandong Weiming Biomedical Co., Ltd. (“Xiamen Weiming”), received a total of RMB 5 million in government incentives related to earnings on August 30, 2023, accounting for 34.04% of the company's most recent audited net profit attributable to shareholders of listed companies.
未名医药(002581.SZ)：收到政府奖励资金500万元
Unnamed Medicine (002581.SZ): Received 5 million yuan in government incentives
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.